CurriculumDeveloping CountriesEducation, Medical, Graduate
Dr. Daniel E. Kenady, MD
NPI1699724021
- Medicare services, 2021
- 297
- Part D claims, 2020
- 11
- Publications
- 5
- Clinical trials
- 1
- MIPS score, 2024
- 82
- Practice address
- 200 Medical Center Drive, Hazard, KY 41701
- Practice phone
- Call (606) 487-7510
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
ARH Medical and Specialty Associates - Hazard
Rural Health Clinic - Hospital-Owned · Hazard, Kentucky
Find Dr. Kenady's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Daniel E. Kenady is a surgical oncologist in Hazard, Kentucky
Dr. Kenady practices at ARH Medical and Specialty Associates - Hazard in Hazard, Kentucky.
Dr. Kenady's NPI, 1699724021, was assigned on May 10, 2006. Dr. Kenady holds Kentucky license 20699.
NPI and contact details
- NPI
- 1699724021NPI Registry (opens in a new tab)
- NPI enumeration date
- May 10, 2006
- NPI status
- Active
- Practice phone
- (606) 487-7510
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Daniel E. Kenady practices at 2 locations in Hazard, Kentucky
Dr. Kenady's primary practice is ARH Medical and Specialty Associates - Hazard, at 200 Medical Center Drive, Hazard, KY 41701. The practice phone is (606) 487-7510. The NPI Registry lists Dr. Kenady's practice address as 210 Black Gold Blvd, Hazard, KY 41701.
- ARH Medical and Specialty Associates - HazardPrimary200 Medical Center Drive, Hazard, KY 41701Phone(606) 487-7510
- NPI Registry address210 Black Gold Blvd, Hazard, KY 41701 · Perry CountyPhone(606) 439-6782
Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Practice Data
Dr. Daniel E. Kenady is affiliated with 1 site of care and 2 medical groups
Dr. Kenady's primary practice is ARH Medical and Specialty Associates - Hazard in Hazard, Kentucky. The medical group on file is University of Kentucky General Pediatrics. Dmand AI also links Dr. Kenady to 1 more medical group, named with a free account.
ARH Medical and Specialty Associates - HazardPrimary
Sources: Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Daniel E. Kenady's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kenady practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| ARH Medical and Specialty Associates - Hazard | Available with a free account |
| +1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Kenady practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Daniel E. Kenady is one of 28 surgical oncologists in Kentucky
Surgical oncology is Dr. Kenady's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Kenady is licensed in Kentucky.
Specialties and state licenses
- Surgical oncology, KentuckyPrimary
Surgical oncologists near Dr. Kenady
Counts of surgical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Daniel E. Kenady billed Medicare for 297 services in 2021
CMS data shows 297 Medicare services from Dr. Kenady across 8 procedure codes in 2021. Medicare paid $10,802 for them.
Medicare services, 2021297
Paid by Medicare$10,802
Procedure codes8
Dr. Kenady's Medicare services by type, 2020 to 2021
- 2020
- 2021
- Office and hospital visits
- 2020: 2372021: 15535%
- Surgery
- 2020: 732021: 14295%
Where Dr. Kenady's Medicare services took place, 2021
- In an office28496%
- In a facility134%
Dr. Kenady compared with the Kentucky median for surgical oncologists, 2021
- Dr. Kenady
- Kentucky median
- Medicare services
- 297vs 22234% above
- Part D claims
- 11vs 5178% below
Medians across 27 surgical oncologists in Kentucky with Dmand AI profiles that report each measure.
Dr. Kenady's most billed Medicare procedure codes, 2021
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kenady?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kenady and other surgical oncologists in Kentucky.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Daniel E. Kenady wrote 11 Medicare Part D claims in 2020
In 2020, Dr. Kenady wrote 11 Medicare Part D claims. They cover 1 drug, with $115 in total drug cost. In 2019, CMS named 11 claims across 1 drug.
Part D claims, 202011
Drugs named by CMS1
Total drug cost$115
Dr. Kenady's most prescribed drugs by claims, 2020
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2019 to 2020
- 2019
- 2020
- Claims for drugs CMS names
- 2019: 112020: 11No change
Drugs named by CMS: 1 in 2020, 1 in 2019.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
Dr. Daniel E. Kenady scored 82 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Kenady for performance year 2024, reported through an alternative payment model (APM).
Dr. Kenady's MIPS scores, performance year 2024
- 82of 100Final score
- 47.1of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find surgical oncologists like Dr. Kenady by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Daniel E. Kenady has 5 publications on record
Dmand AI links 5 papers to Dr. Kenady, published from 2011 to 2014. Dr. Kenady's most frequent co-authors are William R. Carroll, MD, Robert W. Dolan, MD and John F. Gleason, MD.
Papers5
Years published2011 to 2014
Dr. Kenady's papers by year, 2011 to 2014
Dr. Kenady's most frequent co-authors
- William R. Carroll, MD1 shared paper
- Robert W. Dolan, MD1 shared paper
- John F. Gleason, MD1 shared paper
Recent publications by Dr. Kenady
Antineoplastic AgentsCarcinoma, Squamous CellCyclophosphamide
Biopsy, NeedleBreast NeoplasmsFatal Outcome
See who Dr. Kenady researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kenady works with, so you can find a warm path to the right surgical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Daniel E. Kenady has worked on 1 clinical trial
Dmand AI links Dr. Kenady to 1 clinical trial. Conditions studied include Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell.
Conditions in Dr. Kenady's trials
- Squamous Cell Carcinoma of Head and Neck
- Carcinoma, Squamous Cell
Investigators on the most trials with Dr. Kenady
- Richard Bryan Bell, DDS, MD1 shared trial
- Steven Hyman Krasnow, MD1 shared trial
- Jason G. Newman, MD1 shared trial
Recent clinical trials with Dr. Kenady
IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity (opens in a new tab)
CompletedPhase 2
Squamous Cell Carcinoma of Head and NeckCarcinoma, Squamous CellIRX-2CyclophosphamideIndomethacin
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Daniel E. Kenady received $6,744 in industry payments from 2016 to 2024
CMS Open Payments shows 39 general payments to Dr. Kenady from 31 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 89% of the total. NX Development Corp. paid the most, $6,000.
General payments to Dr. Kenady by program year, 2016 to 2024
General payments to Dr. Kenady by kind, 2016 to 2024
$6.7Kin total
- Consulting fees$6,00089%
- Food and beverage$72511%
- Education$180%
Companies that paid Dr. Kenady the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Daniel E. Kenady's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Daniel E. Kenady
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Daniel E. Kenady's NPI number?
Dr. Daniel E. Kenady's NPI number is 1699724021. It was assigned on May 10, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Daniel E. Kenady?
Dr. Daniel E. Kenady is a surgical oncologist in Hazard, Kentucky. The primary specialty in the NPI Registry is Surgical Oncology Physician (taxonomy code 2086X0206X).
Where does Dr. Daniel E. Kenady practice?
Dr. Kenady practices at 200 Medical Center Drive, Hazard, KY 41701. Dr. Kenady also practices at 210 Black Gold Blvd, Hazard, KY 41701. Dr. Kenady's primary practice is ARH Medical and Specialty Associates - Hazard in Hazard, Kentucky. Dmand AI also links Dr. Kenady to 1 medical group.
What is Dr. Daniel E. Kenady's office phone number?
The practice phone on file for Dr. Kenady is (606) 487-7510.
What is Dr. Daniel E. Kenady's medical license number?
Dr. Kenady holds Kentucky license 20699.
What medical group is Dr. Daniel E. Kenady part of?
Dr. Kenady is linked to University of Kentucky General Pediatrics. Dmand AI links Dr. Kenady to 1 more medical group.
Does Dr. Daniel E. Kenady accept Medicare?
Yes. CMS data shows Dr. Kenady billed Medicare for 297 services in 2021.
What is Dr. Daniel E. Kenady's MIPS score?
Dr. Kenady's MIPS final score for performance year 2024 is 82 out of 100, reported through an alternative payment model (APM).
What services does Dr. Daniel E. Kenady bill to Medicare?
In 2021, Dr. Kenady's most billed Medicare services were surgery: skin and soft tissue (17003), office visit, new patient (99203) and office visit, established patient (99213).
What drugs does Dr. Daniel E. Kenady prescribe most?
In 2020 Medicare Part D data, Dr. Kenady's most prescribed drugs by claims were Hydrocodone-Acetaminophen.
Show 4 more questionsShow fewer questions
Has Dr. Daniel E. Kenady received payments from drug or device companies?
CMS Open Payments shows $6,744 in general payments to Dr. Kenady from 31 companies from 2016 to 2024. The largest total came from NX Development Corp.
How long has Dr. Daniel E. Kenady been practicing?
Dr. Kenady's NPI was assigned in 2006.
Does Dr. Daniel E. Kenady do research?
Dmand AI links 5 publications to Dr. Kenady, published from 2011 to 2014. Dr. Kenady has worked on 1 clinical trial.
Who does Dr. Daniel E. Kenady publish with?
Dr. Kenady's most frequent co-authors are William R. Carroll, MD (1 shared paper), Robert W. Dolan, MD (1 shared paper) and John F. Gleason, MD (1 shared paper).
Selling to surgical oncology practices?
See surgical oncologists in Kentucky by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card